Thesis Care Lands $45M to Revolutionize Healthcare with AI-Powered Teams
March 29, 2026, 9:44 pm
Thesis Care, formerly Trovo Health, has secured $45M in Series A funding, boosting its total to $60M. Oak HC/FT led the round. The NYC firm leverages an AI-powered platform, combining AI agents with expert clinicians. This model addresses critical healthcare needs: scaling clinical capacity and drastically cutting administrative burden. Funds will expand operations and development. Major healthcare providers like US Heart & Vascular and Essen Health Care already deploy Thesis Care's transformative technology. The company, founded by former Cedar executives, reshapes clinical operations and care management, driving a new era of efficiency in medicine.
Thesis Care announced a pivotal $45 million Series A funding round. This significant investment pushes their total capital raised to $60 million. Oak HC/FT spearheaded the financing. CRV and Black Opal Ventures also participated. Angel investors contributed to the round. This capital infusion signals strong confidence in Thesis Care's innovative approach. It empowers the company's next phase of growth.
The New York City-based firm targets a critical challenge in healthcare. Providers face immense administrative burdens. Clinical capacity remains strained. Thesis Care offers a groundbreaking solution. They deploy an AI-powered care team platform. This system delivers scalable clinical capacity. It combines advanced AI agents with skilled human clinicians.
This is not a traditional software-as-a-service model. Thesis Care does not sell tools for hospital staff to learn. Instead, it operates an end-to-end service. AI agents execute complex clinical operations. They manage care workflows. Expert clinicians-in-the-loop oversee these processes. The platform delivers finished results directly to providers. This reduces manual effort. It frees up valuable staff time.
The impact is substantial. Thesis Care radically reduces administrative overhead. Existing clinic workflows remain intact. This seamless integration is key. It minimizes disruption during adoption. Healthcare organizations can focus on patient care. They offload tedious, time-consuming tasks to the AI-powered teams.
The company's vision originated in 2024. Dr. Niren Gandra serves as CEO. Aditya Pandyaram is CPO. Both leaders are former executives from Cedar. Cedar is a patient financial engagement giant. Their previous experience informed Thesis Care's foundational strategy. They understood the complexities of healthcare operations. They saw the potential for intelligent automation.
Thesis Care has already demonstrated significant traction. Following successful design partnerships in 2024 and 2025, deployment expanded. The platform now operates across thousands of providers. Major clients include prominent healthcare organizations. US Heart & Vascular benefits from Thesis Care's technology. Essen Health Care leverages the platform. Springfield Clinic is another key partner. Allied Digestive Health also utilizes their services. This broad adoption validates the model. It proves its effectiveness in diverse clinical settings.
The newly secured funds will fuel aggressive expansion. Thesis Care plans to broaden its operations. Development efforts will intensify. This means enhancing existing AI capabilities. It includes exploring new applications for the platform. The goal is to reach more healthcare providers. It aims to impact more patients nationwide.
AI in healthcare is rapidly evolving. Thesis Care positions itself at the forefront. Their hybrid model is particularly compelling. It combines the efficiency of artificial intelligence with human expertise. This "clinician-in-the-loop" approach ensures quality. It maintains crucial human oversight. This balance is vital for patient safety and ethical considerations.
The investment reflects a broader market trend. Investors increasingly back AI-driven solutions in healthcare. These technologies promise greater efficiency. They offer improved access to care. They can potentially lower costs. Thesis Care exemplifies this potential. Their platform addresses immediate, tangible pain points for providers.
Reducing administrative burden is paramount. Healthcare professionals spend excessive time on documentation. They manage complex scheduling. They navigate intricate billing procedures. These tasks divert attention from patients. Thesis Care offers a pathway to reclaim that time. It allows clinicians to operate at the top of their licenses.
Scalable clinical capacity is another critical need. Demand for healthcare services often outstrips supply. Staffing shortages exacerbate the problem. Thesis Care's AI agents augment human teams. They allow organizations to handle more volume. They do so without proportionally increasing staff. This creates a more resilient healthcare system.
The company's rebrand from Trovo Health to Thesis Care reflects its clear mission. It underscores a commitment to delivering definitive, impactful solutions. The name change signifies a mature strategy. It highlights a focus on core challenges.
This Series A funding round marks a significant milestone. It propels Thesis Care forward. The company is poised for substantial growth. It aims to transform how clinical operations are managed. Its AI-powered care teams are set to redefine efficiency in American healthcare. The future of healthcare delivery appears brighter with such innovative solutions.
Thesis Care announced a pivotal $45 million Series A funding round. This significant investment pushes their total capital raised to $60 million. Oak HC/FT spearheaded the financing. CRV and Black Opal Ventures also participated. Angel investors contributed to the round. This capital infusion signals strong confidence in Thesis Care's innovative approach. It empowers the company's next phase of growth.
The New York City-based firm targets a critical challenge in healthcare. Providers face immense administrative burdens. Clinical capacity remains strained. Thesis Care offers a groundbreaking solution. They deploy an AI-powered care team platform. This system delivers scalable clinical capacity. It combines advanced AI agents with skilled human clinicians.
This is not a traditional software-as-a-service model. Thesis Care does not sell tools for hospital staff to learn. Instead, it operates an end-to-end service. AI agents execute complex clinical operations. They manage care workflows. Expert clinicians-in-the-loop oversee these processes. The platform delivers finished results directly to providers. This reduces manual effort. It frees up valuable staff time.
The impact is substantial. Thesis Care radically reduces administrative overhead. Existing clinic workflows remain intact. This seamless integration is key. It minimizes disruption during adoption. Healthcare organizations can focus on patient care. They offload tedious, time-consuming tasks to the AI-powered teams.
The company's vision originated in 2024. Dr. Niren Gandra serves as CEO. Aditya Pandyaram is CPO. Both leaders are former executives from Cedar. Cedar is a patient financial engagement giant. Their previous experience informed Thesis Care's foundational strategy. They understood the complexities of healthcare operations. They saw the potential for intelligent automation.
Thesis Care has already demonstrated significant traction. Following successful design partnerships in 2024 and 2025, deployment expanded. The platform now operates across thousands of providers. Major clients include prominent healthcare organizations. US Heart & Vascular benefits from Thesis Care's technology. Essen Health Care leverages the platform. Springfield Clinic is another key partner. Allied Digestive Health also utilizes their services. This broad adoption validates the model. It proves its effectiveness in diverse clinical settings.
The newly secured funds will fuel aggressive expansion. Thesis Care plans to broaden its operations. Development efforts will intensify. This means enhancing existing AI capabilities. It includes exploring new applications for the platform. The goal is to reach more healthcare providers. It aims to impact more patients nationwide.
AI in healthcare is rapidly evolving. Thesis Care positions itself at the forefront. Their hybrid model is particularly compelling. It combines the efficiency of artificial intelligence with human expertise. This "clinician-in-the-loop" approach ensures quality. It maintains crucial human oversight. This balance is vital for patient safety and ethical considerations.
The investment reflects a broader market trend. Investors increasingly back AI-driven solutions in healthcare. These technologies promise greater efficiency. They offer improved access to care. They can potentially lower costs. Thesis Care exemplifies this potential. Their platform addresses immediate, tangible pain points for providers.
Reducing administrative burden is paramount. Healthcare professionals spend excessive time on documentation. They manage complex scheduling. They navigate intricate billing procedures. These tasks divert attention from patients. Thesis Care offers a pathway to reclaim that time. It allows clinicians to operate at the top of their licenses.
Scalable clinical capacity is another critical need. Demand for healthcare services often outstrips supply. Staffing shortages exacerbate the problem. Thesis Care's AI agents augment human teams. They allow organizations to handle more volume. They do so without proportionally increasing staff. This creates a more resilient healthcare system.
The company's rebrand from Trovo Health to Thesis Care reflects its clear mission. It underscores a commitment to delivering definitive, impactful solutions. The name change signifies a mature strategy. It highlights a focus on core challenges.
This Series A funding round marks a significant milestone. It propels Thesis Care forward. The company is poised for substantial growth. It aims to transform how clinical operations are managed. Its AI-powered care teams are set to redefine efficiency in American healthcare. The future of healthcare delivery appears brighter with such innovative solutions.